| Serial Number | 90357314 |
| Word Mark | PURE-EXO |
| Filing Date | Thursday, December 3, 2020 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, February 5, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations for treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemico-pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; drug delivery agents for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological preparations comprising extracellular vesicles known as exosomes for therapeutic applications; extracellular vesicles for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biochemicial drug for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; preparations of microorganisms for medical and veterinary use for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; reagents for use in medical genetic testing; diagnostic reagents for medical use; biological preparations for medical or veterinary purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological reagents for clinical medical use |
| Goods and Services | Biological preparations, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological preparation for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; proteins for the food industry; chemical reagents, other than for medical or veterinary purpose |
| Goods and Services | Biotechnology research; technological research in the field of cell biology; laboratory research in the field of cell biology; pharmaceutical drug development services; genetic testing for scientific research purposes; research in the field of chemistry; drug discovery services; medical research and development services; pharmaceutical research and development services; biopharmaceutical research and development services |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 9, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 9, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 9, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ILIAS Biologics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Daejeon 34014 KR |
| Event Date | Event Description |
| Monday, December 7, 2020 | NEW APPLICATION ENTERED |
| Thursday, May 20, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, February 9, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 5, 2022 | SUSPENSION LETTER WRITTEN |
| Thursday, June 3, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, June 3, 2021 | NON-FINAL ACTION E-MAILED |
| Thursday, June 3, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 3, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, December 4, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 3, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 5, 2022 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, January 5, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Sunday, May 26, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Monday, July 18, 2022 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Wednesday, October 12, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, April 18, 2023 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Thursday, July 6, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Thursday, February 1, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Monday, February 26, 2024 | SUSPENSION INQUIRY WRITTEN |
| Monday, February 26, 2024 | INQUIRY TO SUSPENSION E-MAILED |
| Monday, February 26, 2024 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Monday, June 24, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 24, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 18, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, October 18, 2024 | FINAL REFUSAL E-MAILED |
| Monday, June 24, 2024 | ASSIGNED TO LIE |
| Friday, October 18, 2024 | FINAL REFUSAL WRITTEN |
| Monday, October 21, 2024 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Monday, October 21, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, October 21, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, October 21, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, February 5, 2025 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, February 5, 2025 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, October 23, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, October 21, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |